Literature DB >> 11327275

Robustness and generalizability of smallest detectable difference in radiological progression.

M N Lassere1, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery, M Boers.   

Abstract

The smallest detectable difference (SDD) reflects that component of a measure statistically attributable to error from the measurement process itself. As such it is an irreducible component of the inherent variability in measurements in clinical trials and will affect their design, whether randomized or observational. Even though the application of the SDD concept to assaying radiographs in rheumatoid arthritis is relatively new and not well understood, systematic work on the influences of radiographic SDD can be done. This report describes the effects of a number of clinical aspects of the disease and operational aspects of trials on the values of the SDD of radiographic progression data. We show that if conditions affecting SDD are known and kept constant across datasets, the SDD of radiological progression from one study may be generalizable to other studies. However, if any one condition varies, the SDD is distinctly unrobust and cannot be generalized to other studies.

Entities:  

Mesh:

Year:  2001        PMID: 11327275

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Interpreting radiographic data in rheumatoid arthritis.

Authors:  P A Ory
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

2.  Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study.

Authors:  Katherine P Liao; Michael E Weinblatt; Jing Cui; Christine Iannaccone; Lori B Chibnik; Bing Lu; Jonathan S Coblyn; Nancy A Shadick; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2011-03-29       Impact factor: 7.580

3.  Estimates of minimal clinically important improvments vary with the responsiveness of the sample.

Authors:  Michael M Ward; Maria I Alba
Journal:  J Clin Epidemiol       Date:  2021-11-06       Impact factor: 6.437

4.  Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis.

Authors:  Glenn Haugeberg; Michael J Green; Philip G Conaghan; Mark Quinn; Richard Wakefield; Susanna M Proudman; Sheena Stewart; Elizabeth Hensor; Paul Emery
Journal:  Ann Rheum Dis       Date:  2007-05-09       Impact factor: 19.103

5.  The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials.

Authors:  Ennio Giulio Favalli; Francesca Pregnolato; Martina Biggioggero; Pier Luigi Meroni
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-08       Impact factor: 5.346

6.  Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis.

Authors:  Fausto Salaffi; Marina Carotti; Alessandro Ciapetti; Stefania Gasparini; Emilio Filippucci; Walter Grassi
Journal:  BMC Musculoskelet Disord       Date:  2011-05-30       Impact factor: 2.362

7.  ICRS Recommendation Document: Patient-Reported Outcome Instruments for Use in Patients with Articular Cartilage Defects.

Authors:  Ewa M Roos; Luella Engelhart; Jonas Ranstam; Allen F Anderson; Jay J Irrgang; Robert G Marx; Yelverton Tegner; Aileen M Davis
Journal:  Cartilage       Date:  2011-04       Impact factor: 4.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.